Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Conavi Medical Corp V.TMD


Primary Symbol: T.TMD

Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.


TSX:TMD - Post by User

Bullboard Posts
Post by NikolaTeslaon Jul 22, 2020 12:44pm
253 Views
Post# 31302669

Elon, where art thou?

Elon, where art thou?As Elon Musk completes his neural link technology. We get a taste of the future. (Foreseeable) The MIS application is almost expected for anything related to the brain or the spine. You do not have to be an expert to understand that. The single-port robotic surgical system has broad and diverse applications related to augmentation and the future of bioengineering. Some may doubt the fact we are in a new era. Many mistakes will be made of course. Yet with precise instruments and tools such as TMDs system. The number of mistakes, at least on the accountable level can be dramatically reduced. This is beyond just the world of modern medicine and has wider implications. Yet, unknown to most of the medical community. My hope is that Elon Musk, takes this company under his wing, touching it with his magic. Good luck to all in their endeavours.
Bullboard Posts